MedWatch

EU Commission ends Danish HERA dreams – but could provide new opportunities for the pharmaceutical industry

With a budget potentially exceeding EUR 47.1bn (DKK 350bn), the EU Commission wants to establish a new agency to ward against future health crises. While the financial makeup is uncertain, good news for future clinical trials might be on the way.

One of the European Commissions Vice-Presidents, Margaritis Schinas (left), presented the HERA proposal on Thursday, alongside with Commissioner for Health and Food Safety Stella Kyriakides and Commissioner for Internal Market Thierry Breton. | Photo: FRANCOIS WALSCHAERTS/AFP / AFP

Covid-19 has brought many hard-learned lessons, both financial and human. Hence, a new deparment to anticipate and fend off future health emergencies is being established on European soil as early as next year.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs